Evidence map›Paper›PMID 31516717›Full record

ArticleCanadian journal of kidney health and disease2019

Capacity of Kidney Care in Canada: Identifying Barriers and Opportunities.

Meaghan Lunney, Arian Samimi, Mohamad A Osman, Kailash Jindal, Natasha Wiebe, Feng Ye, David W Johnson, Adeera Levin, Aminu K Bello

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meaghan LunneyDepartment of Community Health Sciences, University of Calgary, Calgary, Canada.ORCID https://orcid.org/0000-0003-4954-0529
Arian SamimiDepartment of Medicine, University of Alberta, Edmonton, Canada.
Mohamad A OsmanDepartment of Medicine, University of Alberta, Edmonton, Canada.
Kailash JindalDepartment of Medicine, University of Alberta, Edmonton, Canada.
Natasha WiebeDepartment of Medicine, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0002-5613-1582
Feng YeDepartment of Medicine, University of Alberta, Edmonton, Canada.
David W JohnsonCentre for Kidney Disease Research, The University of Queensland at Princess Alexandra Hospital, Brisbane, Australia.
Adeera LevinDivision of Nephrology, The University of British Columbia, Vancouver, Canada.
Aminu K BelloDepartment of Medicine, University of Alberta, Edmonton, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is a significant health problem in Canada. Understanding the capacity of the Canadian health-care system to deliver kidney care is important to provide optimal care.

objectiveTo compare Canada's position in relation to countries of similar economic standing.

designCross-sectional electronic survey.

settingMember countries of the Organisation for Economic Co-operation and Development (OECD) that participated in the survey.

participantsNephrologists, other physicians, policymakers, and other professionals with relevant expertise in kidney care. MEASUREMENTS: Not applicable.

methodsA survey administered by the International Society of Nephrology assessed the global capacity of kidney care delivery. Data from participating OECD countries were analyzed using descriptive statistics to compare Canada's position.

resultsOf the participating countries, most funded kidney care services (non-medication) by government (transplantation: 85%, dialysis: 81%, acute kidney injury (AKI): 77%). Most countries covered medication. Canada reported a public funding model for kidney services and a mix of public and private sources for medication. Nephrologists and nephrology trainee densities were lower in Canada compared to the median (15.33 vs. 25.82 and 1.74 vs. 3.94, respectively). CKD was recognized as a health priority in five countries, but not in Canada. Registries for CKD did not exist in most (24/26) countries. Canada followed a national strategy for noncommunicable diseases, but this was not specific to CKD care, dialysis, or transplantation. LIMITATIONS: Risks of recall bias or social desirability bias are present. Differences in a number of factors could influence discrepancies among countries and were not explored. Responses reflected the existence of practices, policies, and strategies, and may not necessarily describe action or impact. Capacity of care is not equal across all regions and provinces within Canada; however, the findings are reported on a national level and therefore may not appropriately address variability.

conclusionsThis study describes the capacity for kidney care at a national level within the context of the Canadian health system. The Canadian health-care system is well funded by the government; however, there are areas that could be improved to increase the optimization of kidney care provided.

Indexed as

Canadacapacitykidney care structureOECDsurvey

Identifiers

PMID31516717
PMCPMC6719472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.